var singsData = [{"date":new Date(2012,1,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,1),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45537","showOnAxis":true},{"date":new Date(2012,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,10,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains HCP to Hold. Target Price is $46; previously $45.","showOnAxis":false},{"date":new Date(2012,10,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,2,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2012,3,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,3,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45537","showOnAxis":true},{"date":new Date(2012,5,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,5,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,6,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HCP to Neutral. Target Price is $43; previously $42.","showOnAxis":false},{"date":new Date(2012,6,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,6,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,31),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2012 Q2's earning $0.69 per share and revenue $464.4MM. This beats analyst's estimated EPS $0.68, beats estimated revenue $461.51MM.","showOnAxis":false},{"date":new Date(2012,7,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains HCP to Buy. Target Price is $50; previously $49.","showOnAxis":false},{"date":new Date(2012,7,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HCP to Neutral. Target Price is $44; previously $43.","showOnAxis":false},{"date":new Date(2012,7,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45537","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,17),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains HCP to Hold. Target Price is $45; previously $42.","showOnAxis":false},{"date":new Date(2012,9,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,30),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"HCP reports 2012 Q3's earning $0.67 per share and revenue $475.48MM. This misses analyst's estimated EPS $0.69, beats estimated revenue $467.72MM.","showOnAxis":false},{"date":new Date(2013,0,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"KeyBanc upgrades HCP to Hold from Underweight.","showOnAxis":false},{"date":new Date(2013,0,31),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47814","showOnAxis":true},{"date":new Date(2013,1,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,12),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2012 Q4's earning $0.72 per share  This beats analyst's estimated EPS $0.71.","showOnAxis":false},{"date":new Date(2013,1,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays initiates coverage on HCP to Equal-Weight. Target Price is $50.","showOnAxis":false},{"date":new Date(2013,10,19),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades HCP to Hold from Buy; previously $48.","showOnAxis":false},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,2,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"BMO Capital upgrades HCP to Market Perform from Underperform.","showOnAxis":false},{"date":new Date(2013,2,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades HCP to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2013,2,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs assumes HCP to Neutral. Target Price is $53.","showOnAxis":false},{"date":new Date(2013,3,2),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains HCP to Buy. Target Price is $53; previously $50.","showOnAxis":false},{"date":new Date(2013,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,30),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2013 Q1's earning $0.74 per share and revenue $516.3MM. This beats analyst's estimated EPS $0.72, beats estimated revenue $512.82MM.","showOnAxis":false},{"date":new Date(2013,3,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,3,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47814","showOnAxis":true},{"date":new Date(2013,4,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HCP to Neutral. Target Price is $54; previously $50.","showOnAxis":false},{"date":new Date(2013,6,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,6,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,6,2),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,6,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,6,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,1),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47814","showOnAxis":true},{"date":new Date(2013,7,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Hilliard Lyons upgrades HCP to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2013,8,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,8,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,8,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,8,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,8,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,8,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains HCP to Buy. Target Price is $51; previously $53.","showOnAxis":false},{"date":new Date(2013,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,9,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2013 Q3's earning $0.79 per share  This beats analyst's estimated EPS $0.76.","showOnAxis":false},{"date":new Date(2013,9,3),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"RBC Capital downgrades HCP to Underperform from Sector Perform. Target Price is $38; previously $49.","showOnAxis":false},{"date":new Date(2013,9,31),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47814","showOnAxis":true},{"date":new Date(2014,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,11),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2013 Q4's earning $0.76 per share and revenue $530.3MM. This beats analyst's estimated EPS $0.74, beats estimated revenue $510.39MM.","showOnAxis":false},{"date":new Date(2014,1,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,1,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,1,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.49636","showOnAxis":true},{"date":new Date(2014,10,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades HCP to Overweight from Equal-Weight.","showOnAxis":false},{"date":new Date(2014,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.49636","showOnAxis":true},{"date":new Date(2014,11,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,11,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,19),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Material Impairments\r\n","showOnAxis":true},{"date":new Date(2014,11,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HCP to Neutral. Target Price is $44; previously $43.","showOnAxis":false},{"date":new Date(2014,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,2,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,2,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,2,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,2,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,2,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,3,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains HCP to Equal-Weight. Target Price is $42; previously $39.","showOnAxis":false},{"date":new Date(2014,4,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.49636","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2014,7,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,7,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,7,29),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HCP to Equal-Weight. Target Price is $44; previously $42.","showOnAxis":false},{"date":new Date(2014,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.49636","showOnAxis":true},{"date":new Date(2014,9,21),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Jefferies downgrades HCP to Hold from Buy. Target Price is $45; previously $47.","showOnAxis":false},{"date":new Date(2014,9,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"ISI Group initiates coverage on HCP to Neutral. Target Price is $42.","showOnAxis":false},{"date":new Date(2015,0,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,0,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,14),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Wells Fargo downgrades HCP to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,0,21),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,26),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Mizuho downgrades HCP to Neutral from Buy. Target Price is $49; previously $50.","showOnAxis":false},{"date":new Date(2015,0,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HCP to Equal-Weight. Target Price is $47; previously $45.","showOnAxis":false},{"date":new Date(2015,1,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,25),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades HCP to Equal-Weight from Overweight. Target Price is $45; previously $50.","showOnAxis":false},{"date":new Date(2015,1,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.51457","showOnAxis":true},{"date":new Date(2015,1,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,1,8),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2015 Q3's earning $0.79 per share and revenue $657.953MM. This beats analyst's estimated EPS $0.77, beats estimated revenue $602.18MM.","showOnAxis":false},{"date":new Date(2015,10,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.51457","showOnAxis":true},{"date":new Date(2015,11,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,11,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Material Impairments\r\n","showOnAxis":true},{"date":new Date(2015,2,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades HCP to Buy from Neutral. Target Price is $47; previously $41.","showOnAxis":false},{"date":new Date(2015,3,20),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,3,30),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,3,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital initiates coverage on HCP to Underperform. Target Price is $42.","showOnAxis":false},{"date":new Date(2015,4,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,4,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,5),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BMO Capital maintains HCP to Underperform. Target Price is $38; previously $40.","showOnAxis":false},{"date":new Date(2015,4,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital maintains HCP to Underperform. Target Price is $38; previously $40.","showOnAxis":false},{"date":new Date(2015,4,7),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.51457","showOnAxis":true},{"date":new Date(2015,5,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Mizuho upgrades HCP to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2015,5,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,5,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,5,18),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,5,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,5,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,5,24),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Material Impairments\r\n","showOnAxis":true},{"date":new Date(2015,5,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,5,26),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,5,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Argus Research maintains HCP to Buy. Target Price is $43; previously $49.","showOnAxis":false},{"date":new Date(2015,5,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains HCP to Hold. Target Price is $40; previously $46.","showOnAxis":false},{"date":new Date(2015,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,4),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,7,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.51457","showOnAxis":true},{"date":new Date(2015,8,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,8,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,8,10),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Material Impairments\r\n","showOnAxis":true},{"date":new Date(2015,8,21),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades HCP to Sell from Neutral.","showOnAxis":false},{"date":new Date(2015,8,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Mizuho maintains HCP to Neutral. Target Price is $41; previously $39.","showOnAxis":false},{"date":new Date(2015,8,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Goldman Sachs downgrades HCP to Sell from Neutral. Target Price is $38; previously $40.","showOnAxis":false},{"date":new Date(2015,8,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Evercore ISI Group maintains HCP to Hold. Target Price is $39; previously $42.","showOnAxis":false},{"date":new Date(2016,0,12),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Jefferies downgrades HCP to Underperform from Hold.","showOnAxis":false},{"date":new Date(2016,0,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,0,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,0,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,0,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,0,4),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Argus Research downgrades HCP to Hold from Buy.","showOnAxis":false},{"date":new Date(2016,0,6),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Barclays downgrades HCP to Underweight from Equal-Weight. Target Price is $37; previously $40.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains HCP to Buy. Target Price is $31; previously $41.","showOnAxis":false},{"date":new Date(2016,1,11),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Stifel Nicolaus downgrades HCP to Sell from Hold.","showOnAxis":false},{"date":new Date(2016,1,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains HCP to Underperform. Target Price is $22; previously $30.","showOnAxis":false},{"date":new Date(2016,1,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.52368","showOnAxis":true},{"date":new Date(2016,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,1),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2016 Q3's earning $0.72 per share and revenue $654.27MM. This beats analyst's estimated EPS $0.71, beats estimated revenue $634.8MM.","showOnAxis":false},{"date":new Date(2016,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,14),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,10,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades HCP to Hold from Sell.","showOnAxis":false},{"date":new Date(2016,10,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Mizuho upgrades HCP to Buy from Neutral. Target Price is $32; previously $31.","showOnAxis":false},{"date":new Date(2016,10,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades HCP to Sector Perform from Underperform.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.37","showOnAxis":true},{"date":new Date(2016,11,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"BMO Capital upgrades HCP to Market Perform from Underperform.","showOnAxis":false},{"date":new Date(2016,2,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains HCP to Underweight. Target Price is $33; previously $37.","showOnAxis":false},{"date":new Date(2016,2,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains HCP to Neutral. Target Price is $35; previously $39.","showOnAxis":false},{"date":new Date(2016,2,16),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"UBS downgrades HCP to Neutral from Buy.","showOnAxis":false},{"date":new Date(2016,2,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,2,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,2,23),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,3,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains HCP to Neutral. Target Price is $31; previously $27.5.","showOnAxis":false},{"date":new Date(2016,3,28),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,4,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Jefferies upgrades HCP to Hold from Underperform. Target Price is $32; previously $25.","showOnAxis":false},{"date":new Date(2016,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,4,12),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains HCP to Neutral. Target Price is $34; previously $31.","showOnAxis":false},{"date":new Date(2016,4,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.52368","showOnAxis":true},{"date":new Date(2016,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,4,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2016 Q1's earning $0.69 per share and revenue $640.782MM. This meets analyst's estimated EPS $0.69, beats estimated revenue $621.93MM.","showOnAxis":false},{"date":new Date(2016,5,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades HCP to Underweight from Equal-Weight. Target Price is $32.","showOnAxis":false},{"date":new Date(2016,6,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,6,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,6,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,11),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,6,26),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Raymond James initiates coverage on HCP to Underperform.","showOnAxis":false},{"date":new Date(2016,6,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades HCP to Neutral.","showOnAxis":false},{"date":new Date(2016,7,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains HCP to Neutral. Target Price is $38; previously $35.","showOnAxis":false},{"date":new Date(2016,7,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains HCP to Neutral. Target Price is $38; previously $34.","showOnAxis":false},{"date":new Date(2016,7,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"BTIG Research initiates coverage on HCP to Neutral.","showOnAxis":false},{"date":new Date(2016,7,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.52368","showOnAxis":true},{"date":new Date(2016,7,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,9),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,9),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCP reports 2016 Q2's earning $0.74 per share and revenue $662.176MM. This beats analyst's estimated EPS $0.7, beats estimated revenue $635.14MM.","showOnAxis":false},{"date":new Date(2016,8,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,8,27),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,13),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,9,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,9,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,17),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2016,9,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,3),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,9,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2016,9,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,9,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,31),"type":"sign","text":"8K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,9,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades HCP to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2017,0,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades HCP to Buy from Neutral. Target Price is $35; previously $29.","showOnAxis":false},{"date":new Date(2017,0,5),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays reinstates HCP to Equal-Weight. Target Price is $32.","showOnAxis":false}];